Valentina De Chiara
Via Montpellier 1
Rome, 00133, Italy
Rome, 00133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids.
Journal: CNS neuroscience & therapeutics
Published: January 27, 2014
Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: October 25, 2013
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.
Journal: PloS one
Published: January 12, 2013
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 13, 2012
Interleukin-1β causes anxiety by interacting with the endocannabinoid system.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: October 05, 2012
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity.
Journal: Brain : a journal of neurology
Published: September 26, 2012
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: August 29, 2012
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 12, 2012
Inflammation inhibits GABA transmission in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 16, 2012
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Journal: Experimental neurology
Published: March 02, 2012
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
Journal: European journal of neurology
Published: February 08, 2012
Last Updated: 09/26/2026